Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bioasis Technologies Inc. V.BTI

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.


TSXV:BTI - Post by User

Comment by craighenryon Dec 13, 2022 2:14pm
105 Views
Post# 35169087

RE:I am not happy with this deal, but......

RE:I am not happy with this deal, but......
craighenry wrote: Take a quick look at MTPs pipeline. 


I dont think ALL is lost here.  Yeah it sucks.  12 plus years and counting...... it sucks.

No point in selling now is there? 

Take a look at the link below  and the Glioblastoma trials  (then throw in the possibility of XB3)


https://www.midatechpharma.com/news/first-patient-enrolled-in-phase-1-study-of-mtx-110-magic-g1-study-in-patients-with-recurrent-glioblastoma



Also take a quick read of the MidaTech Management Team bios.


You will notice a few Companies, and the possible connections. 

-Shire
-Chiesi 
<< Previous
Bullboard Posts
Next >>